[ad_1] Reviewed by Emily Henderson, B.Sc.November 16, 2020 The first ever randomized Phase 3 clinical trial in patients with advanced anal canal cancer is now open and enrolling patients. Anal cancer is a rare disease. The vast majority (90%) of new cases are of the squamous cell type, associated with …
Read More »
[ad_1] In this second wave of Covid, some, influenced by the doubt maintained by deniers (there is no rebound, the deaths are falsely labeled Covid …) still ask the question of the usefulness of hospitalization. They know patients who have not been signed and, due to the controversy created over …
Read More »
[ad_1] Reviewed by Emily Henderson, B.Sc.October 27, 2020 In recent years, improvements in cancer therapy have led to a significant increase in cancer survival. Experts estimate that by 2022 the United States will have 18 million cancer survivors, but a subset of these survivors will have long-term health problems to …
Read More »
[ad_1] Clovis Oncology (CLVS): Clovis Oncology (CLVS) settled with a variation of -0.11%, pushing the price on the $ 17.97 per share in the recently concluded trading session Friday. The last trading activity showed that the share price fell 56.26% from its minimum of 52 weeks and traded with a …
Read More »